160 related articles for article (PubMed ID: 36927749)
1. [Combined immunodeficiency due to DOCK8 deficiency. State of the art].
Liquidano-Pérez E; Maza-Ramos G; Yamazaki-Nakashimada MA; Barragán-Arévalo T; Lugo-Reyes SO; Scheffler-Mendoza S; Espinosa-Padilla SE; González-Serrano ME
Rev Alerg Mex; 2022 Jul; 69(1):31-47. PubMed ID: 36927749
[TBL] [Abstract][Full Text] [Related]
2. Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.
Su HC; Jing H; Angelus P; Freeman AF
Immunol Rev; 2019 Jan; 287(1):9-19. PubMed ID: 30565250
[TBL] [Abstract][Full Text] [Related]
3. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.
Engelhardt KR; Gertz ME; Keles S; Schäffer AA; Sigmund EC; Glocker C; Saghafi S; Pourpak Z; Ceja R; Sassi A; Graham LE; Massaad MJ; Mellouli F; Ben-Mustapha I; Khemiri M; Kilic SS; Etzioni A; Freeman AF; Thiel J; Schulze I; Al-Herz W; Metin A; Sanal Ö; Tezcan I; Yeganeh M; Niehues T; Dueckers G; Weinspach S; Patiroglu T; Unal E; Dasouki M; Yilmaz M; Genel F; Aytekin C; Kutukculer N; Somer A; Kilic M; Reisli I; Camcioglu Y; Gennery AR; Cant AJ; Jones A; Gaspar BH; Arkwright PD; Pietrogrande MC; Baz Z; Al-Tamemi S; Lougaris V; Lefranc G; Megarbane A; Boutros J; Galal N; Bejaoui M; Barbouche MR; Geha RS; Chatila TA; Grimbacher B
J Allergy Clin Immunol; 2015 Aug; 136(2):402-12. PubMed ID: 25724123
[TBL] [Abstract][Full Text] [Related]
4. Clinical, immunological, and genetic description of a Mexican cohort of patients with DOCK8 deficiency.
Liquidano-Perez E; Maza-Ramos G; Perez Arias BA; Lugo Reyes SO; Barragan Arevalo T; Solorzano-Morales SA; Venegas Montoya E; Staines-Boone AT; Guzmán Cotaya R; Okada S; Picard C; Patin E; Ramirez-Uribe N; Bustamante-Ogando JC; Scheffler-Mendoza SC; Yamazaki-Nakashimada MA; Saez-de-Ocariz M; Espinosa Padilla SE; Gonzalez-Serrano ME
Pediatr Allergy Immunol; 2024 Feb; 35(2):e14073. PubMed ID: 38351896
[TBL] [Abstract][Full Text] [Related]
5. DOCK8 deficiency.
Su HC; Jing H; Zhang Q
Ann N Y Acad Sci; 2011 Dec; 1246():26-33. PubMed ID: 22236427
[TBL] [Abstract][Full Text] [Related]
6. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
Biggs CM; Keles S; Chatila TA
Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients.
Pillay BA; Avery DT; Smart JM; Cole T; Choo S; Chan D; Gray PE; Frith K; Mitchell R; Phan TG; Wong M; Campbell DE; Hsu P; Ziegler JB; Peake J; Alvaro F; Picard C; Bustamante J; Neven B; Cant AJ; Uzel G; Arkwright PD; Casanova JL; Su HC; Freeman AF; Shah N; Hickstein DD; Tangye SG; Ma CS
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31021819
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for DOCK8 deficiency-related severe dermatitis.
Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
[TBL] [Abstract][Full Text] [Related]
9. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
[TBL] [Abstract][Full Text] [Related]
10. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
[TBL] [Abstract][Full Text] [Related]
11. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
13. Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency.
Haskologlu S; Kostel Bal S; Islamoglu C; Aytekin C; Guner S; Sevinc S; Keles S; Kendirli T; Ceylaner S; Dogu F; Ikinciogullari A
Pediatr Allergy Immunol; 2020 Jul; 31(5):515-527. PubMed ID: 32108967
[TBL] [Abstract][Full Text] [Related]
14. Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
Raedler J; Magg T; Rohlfs M; Klein C; Vallée T; Hauck F; Albert MH
J Clin Immunol; 2021 Oct; 41(7):1536-1548. PubMed ID: 34080085
[TBL] [Abstract][Full Text] [Related]
15. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
Aydin SE; Kilic SS; Aytekin C; Kumar A; Porras O; Kainulainen L; Kostyuchenko L; Genel F; Kütükcüler N; Karaca N; Gonzalez-Granado L; Abbott J; Al-Zahrani D; Rezaei N; Baz Z; Thiel J; Ehl S; Marodi L; Orange JS; Sawalle-Belohradsky J; Keles S; Holland SM; Sanal Ö; Ayvaz DC; Tezcan I; Al-Mousa H; Alsum Z; Hawwari A; Metin A; Matthes-Martin S; Hönig M; Schulz A; Picard C; Barlogis V; Gennery A; Ifversen M; van Montfrans J; Kuijpers T; Bredius R; Dückers G; Al-Herz W; Pai SY; Geha R; Notheis G; Schwarze CP; Tavil B; Azik F; Bienemann K; Grimbacher B; Heinz V; Gaspar HB; Aydin R; Hagl B; Gathmann B; Belohradsky BH; Ochs HD; Chatila T; Renner ED; Su H; Freeman AF; Engelhardt K; Albert MH;
J Clin Immunol; 2015 Feb; 35(2):189-98. PubMed ID: 25627830
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of DOCK8 deficiency syndrome.
Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
[TBL] [Abstract][Full Text] [Related]
17. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.
Jing H; Zhang Q; Zhang Y; Hill BJ; Dove CG; Gelfand EW; Atkinson TP; Uzel G; Matthews HF; Mustillo PJ; Lewis DB; Kavadas FD; Hanson IC; Kumar AR; Geha RS; Douek DC; Holland SM; Freeman AF; Su HC
J Allergy Clin Immunol; 2014 Jun; 133(6):1667-75. PubMed ID: 24797421
[TBL] [Abstract][Full Text] [Related]
18. Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE.
Kienzler AK; van Schouwenburg PA; Taylor J; Marwah I; Sharma RU; Noakes C; Thomson K; Sadler R; Segal S; Ferry B; Taylor JC; Blair E; Chapel H; Patel SY
Clin Immunol; 2016 Feb; 163():17-21. PubMed ID: 26680607
[TBL] [Abstract][Full Text] [Related]
19. Dedicator of cytokinesis 8 (DOCK8) deficiency.
Su HC
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):515-20. PubMed ID: 20864884
[TBL] [Abstract][Full Text] [Related]
20. Clinical, immunological and molecular profiles of DOCK8 deficiency in six patients from a tertiary care centre in North India.
Kumar Jindal A; Sil A; Aggarwal R; Tyagi R; Mondal S; Singh A; Barman P; Chawla S; Loganathan SK; Gupta K; Vinay K; Mahajan R; Saikia B; Kaur G; Sharma R; Saka R; Bhatia A; Sankhyan N; Pandiarajan V; Pilania R; Dhaliwal M; Sharma S; Vyas S; Suri D; Rawat A; Singh S
Clin Exp Dermatol; 2024 Feb; 49(3):226-234. PubMed ID: 37815217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
